These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular dissection of the human A Storme J; Cannaert A; Van Craenenbroeck K; Stove CP Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765 [TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor. Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943 [TBL] [Abstract][Full Text] [Related]
4. Assessment of biased agonism at the A Pottie E; Tosh DK; Gao ZG; Jacobson KA; Stove CP Biochem Pharmacol; 2020 Jul; 177():113934. PubMed ID: 32224136 [TBL] [Abstract][Full Text] [Related]
5. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
6. Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers. Gao ZG; Verzijl D; Zweemer A; Ye K; Göblyös A; Ijzerman AP; Jacobson KA Biochem Pharmacol; 2011 Sep; 82(6):658-68. PubMed ID: 21718691 [TBL] [Abstract][Full Text] [Related]
7. A Tosh DK; Salmaso V; Campbell RG; Rao H; Bitant A; Pottie E; Stove CP; Liu N; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA Eur J Med Chem; 2022 Jan; 228():113983. PubMed ID: 34844790 [TBL] [Abstract][Full Text] [Related]
8. Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A Tosh DK; Salmaso V; Rao H; Bitant A; Fisher CL; Lieberman DI; Vorbrüggen H; Reitman ML; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA J Med Chem; 2020 Apr; 63(8):4334-4348. PubMed ID: 32271569 [TBL] [Abstract][Full Text] [Related]
9. Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor. Kozma E; Gizewski ET; Tosh DK; Squarcialupi L; Auchampach JA; Jacobson KA Biochem Pharmacol; 2013 Apr; 85(8):1171-81. PubMed ID: 23376019 [TBL] [Abstract][Full Text] [Related]
10. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429 [TBL] [Abstract][Full Text] [Related]
11. Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists. Tosh DK; Ciancetta A; Warnick E; O'Connor R; Chen Z; Gizewski E; Crane S; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA J Med Chem; 2016 Apr; 59(7):3249-63. PubMed ID: 26890707 [TBL] [Abstract][Full Text] [Related]
12. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268 [TBL] [Abstract][Full Text] [Related]
13. Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways. Gao ZG; Jacobson KA Pharmacol Res; 2008 Apr; 57(4):303-11. PubMed ID: 18424164 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists. Nayak A; Chandra G; Hwang I; Kim K; Hou X; Kim HO; Sahu PK; Roy KK; Yoo J; Lee Y; Cui M; Choi S; Moss SM; Phan K; Gao ZG; Ha H; Jacobson KA; Jeong LS J Med Chem; 2014 Feb; 57(4):1344-54. PubMed ID: 24456490 [TBL] [Abstract][Full Text] [Related]
15. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch. Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786 [TBL] [Abstract][Full Text] [Related]
16. Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain. Paoletta S; Tosh DK; Finley A; Gizewski ET; Moss SM; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA J Med Chem; 2013 Jul; 56(14):5949-63. PubMed ID: 23789857 [TBL] [Abstract][Full Text] [Related]
17. Purine derivatives as ligands for A3 adenosine receptors. Joshi BV; Jacobson KA Curr Top Med Chem; 2005; 5(13):1275-95. PubMed ID: 16305531 [TBL] [Abstract][Full Text] [Related]
18. Structural Characterization of Agonist Binding to an A Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843 [TBL] [Abstract][Full Text] [Related]
19. A binding kinetics study of human adenosine A Xia L; Kyrizaki A; Tosh DK; van Duijl TT; Roorda JC; Jacobson KA; IJzerman AP; Heitman LH Biochem Pharmacol; 2018 Jul; 153():248-259. PubMed ID: 29305857 [TBL] [Abstract][Full Text] [Related]
20. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions. Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]